How many days before a colonoscopy should tirzepatide (Mounjaro) be stopped in a patient with diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Mounjaro Discontinuation Before Colonoscopy

Stop Mounjaro (tirzepatide) 1 week (7 days) before your colonoscopy to minimize the risk of aspiration during the procedure. 11

Rationale for This Recommendation

Tirzepatide has an elimination half-life of approximately 5 days 1, and the 2025 multidisciplinary UK consensus guideline explicitly recommends stopping weekly GLP-1 receptor agonists (including tirzepatide) one week before procedures requiring anesthesia or deep sedation 11. This timing allows adequate clearance of the medication and restoration of normal gastric emptying.

Why This Matters

  • Delayed gastric emptying: Tirzepatide significantly slows gastric emptying, which persists even with standard fasting protocols 11
  • Aspiration risk: The FDA label specifically warns that "MOUNJARO may increase the chance of food getting into your lungs during surgery or other procedures" 22
  • Colonoscopy considerations: While colonoscopy typically uses moderate sedation rather than general anesthesia, the aspiration risk remains relevant, and the American Society of Anesthesiologists recommends the same precautions 11

Important Clinical Considerations

Glycemic control during the medication holiday:

  • Monitor blood glucose more frequently during the week off tirzepatide
  • You may need temporary adjustments to other diabetes medications
  • The risk of hyperglycemia for one week is substantially lower than the risk of aspiration during the procedure 11

Bowel preparation quality:

  • Stopping tirzepatide also helps ensure adequate bowel preparation, as delayed gastric emptying can interfere with colonoscopy prep effectiveness
  • Consider scheduling your colonoscopy mid-morning rather than very early if possible, as this allows better timing for split-dose bowel preparation 3

After the procedure:

  • Resume tirzepatide at your regular dose after the colonoscopy is complete and you're tolerating oral intake normally
  • No dose adjustment is needed when restarting

Common Pitfall to Avoid

Do not assume that stopping tirzepatide just 1-2 days before the procedure is sufficient—the 5-day half-life means significant drug levels persist for much longer than daily medications. The full week discontinuation is necessary for adequate drug clearance 11.

References

Related Questions

In a patient with type 2 diabetes, can tirzepatide cause shingles reactivation?
Can tirzepatide increase blood glucose levels?
In a 53‑year‑old male on tirzepatide (Mounjaro) 2.5 mg for three months who has a weight‑loss plateau, exercise‑related fatigue, a history of hiatal hernia, recurrent nephrolithiasis, dyslipidemia, and labs showing elevated homocysteine, micro‑albuminuria, low‑normal testosterone, and LDL ≈ 115 mg/dL, what management steps should be taken?
Can diabetes or the medication Mounjaro (tirzepatide) cause urinary retention?
Can Zepbound (tirzepatide) lower blood pressure?
How soon before surgery should GLP‑1 receptor agonist injections be stopped?
For a 17-year-old female with bacterial conjunctivitis, can Polytrim (polymyxin B 0.1 mg/mL + trimethoprim 1 mg/mL) be dosed every 6 hours?
What is gain‑of‑function research and what biosafety and regulatory measures are required for it?
What is the preferred alternative antibiotic regimen for streptococcal pharyngitis in a patient with a documented IgE‑mediated penicillin allergy?
How often should serum sodium be monitored at the 30‑hour point after the patient receives the infusion?
In a patient receiving tolvaptan for SIADH-related hyponatremia, how frequently should serum sodium be monitored after the 30‑hour mark?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.